In last trading session, Caribou Biosciences Inc (NASDAQ:CRBU) saw 0.78 million shares changing hands with its beta currently measuring 2.31. Company’s recent per share price level of $1.31 trading at -$0.1 or -7.09% at ring of the bell on the day assigns it a market valuation of $118.62M. That closing price of CRBU’s stock is at a discount of -535.88% from its 52-week high price of $8.33 and is indicating a premium of 6.87% from its 52-week low price of $1.22.

For Caribou Biosciences Inc (CRBU), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.44. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.42 in the current quarter.

Caribou Biosciences Inc (NASDAQ:CRBU) trade information

Caribou Biosciences Inc’s shares saw a change of -17.61% in year-to-date performance and have moved 0.00% in past 5-day. Caribou Biosciences Inc (NASDAQ:CRBU) showed a performance of -13.82% in past 30-days.

Wall Street analysts have assigned a consensus price target of 3 to the stock, which implies a rise of 56.33% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -129.01% in reaching the projected high whereas dropping to the targeted low would mean a loss of -129.01% for stock’s current value.

Caribou Biosciences Inc (CRBU) estimates and forecasts

This year revenue growth is estimated to fall -73.51% from the last financial year’s standing.

8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.84M for the same. And 2 analysts are in estimates of company making revenue of 2.75M in the next quarter. Company posted 3.56M and 2.43M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -37.16% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -20.17% while estimates for its earnings growth in next 5 years are of -12.22%.

Caribou Biosciences Inc (NASDAQ:CRBU)’s Major holders

BLACKROCK INC. is the top institutional holder at CRBU for having 6.95 million shares of worth $11.39 million. And as of 2024-06-30, it was holding 7.7801 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.0891 of outstanding shares, having a total worth of $7.45 million.

On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.77 shares of worth $3.63 million or 3.06% of the total outstanding shares. The later fund manager was in possession of 2.36 shares on Nov 30, 2024 , making its stake of worth around $3.1 million in the company or a holder of 2.61% of company’s stock.